Iacopino Saverio, Fabiano Gennaro, Sorrenti Paolo, Petretta Andrea, Colella Jacopo, Vilio Alessandro Di, Statuto Giovanni, Diomede Nicolangelo, Artale Paolo, Filannino Pasquale, Pardeo Antonino, Placentino Filippo, Campagna Giuseppe, Peluso Gianluca, Cecchini Edoardo, Cecchini Federico, Speziale Giuseppe, Gaita Fiorenzo
Electrophysiology Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Electrophysiology Department, Anthea Hospital, GVM Care & Research, Bari, Italy.
Front Cardiovasc Med. 2024 Aug 21;11:1449038. doi: 10.3389/fcvm.2024.1449038. eCollection 2024.
Despite the high success rate of radiofrequency catheter ablation (RFCA) in Wolff-Parkinson-White Syndrome (WPW), localizing the successful ablation site can be challenging and may require multiple radiofrequency (RF) applications.
This study aims to evaluate the efficacy of a novel workflow for the automatic and precise identification of accessory pathway ablation site, named Delta Wave Automatic Mapping.
Patients undergoing a first procedure for RF ablation of a manifest accessory pathway were included. Electro-Anatomical Mapping (EAM) was performed with the CARTO 3 system (Biosense Webster, Johnson & Johnson Medical S.p.a., Irvine, CA) leveraging auto-acquisition algorithms already present in the CARTO 3 software. Mapping and ablation were performed with an irrigated tip catheter with contact force sensor. Procedure success was defined as loss of pathway function after ablation. The number of RF applications required and time to effect were measured for each patient. Recurrences were evaluated during follow-up visits. Additionally, at the end of each procedure, historical predictors of ablation success were measured offline to evaluate their relationship with the successful ablation site found with the novel workflow.
A total of 50 patients were analysed (62% APs right and 38% APs left). All 50 APs were successfully eliminated in each procedure with a median Time-to-effect (TTE) of 2.0 (IQR 1.2-3.5) seconds. No AP recurrences during a median follow-up of 10 (IQR 6-13) months were recorded. Offline analysis of successful ablation site revealed a pre-ablation delta/ventricular interval of ≤-10 msec in 52% of the patients and in 100% of the patients the signal related to the Kent bundle was identified.
The novel workflow efficiently localizes APs without requiring manual annotations. Historical endocardial parameters predicting success were measured offline for each case and they corresponded to the ablation target automatically annotated by the proposed workflow. This novel mapping workflow holds promise in enhancing the efficacy of RFCA in the presence of manifest APs.
尽管射频导管消融术(RFCA)治疗预激综合征(WPW)成功率很高,但确定成功的消融部位可能具有挑战性,可能需要多次射频(RF)应用。
本研究旨在评估一种名为Delta波自动标测的新型工作流程在自动精确识别旁路消融部位方面的疗效。
纳入首次接受显性旁路射频消融术的患者。使用CARTO 3系统(Biosense Webster,强生医疗公司,加利福尼亚州欧文市)进行电解剖标测(EAM),利用CARTO 3软件中已有的自动采集算法。使用带接触力传感器的灌注导管尖端进行标测和消融。手术成功定义为消融后旁路功能丧失。测量每位患者所需的RF应用次数和起效时间。在随访期间评估复发情况。此外,在每个手术结束时,离线测量消融成功的历史预测指标,以评估它们与通过新型工作流程找到的成功消融部位的关系。
共分析了50例患者(右旁路62%,左旁路38%)。在每个手术中,所有50条旁路均成功消除,中位起效时间(TTE)为2.0(四分位间距1.2 - 3.5)秒。在中位随访10(四分位间距6 - 13)个月期间未记录到旁路复发。对成功消融部位的离线分析显示,52%的患者消融前delta/心室间期≤ - 10毫秒,100%的患者识别出与肯特束相关的信号。
这种新型工作流程无需手动标注即可有效地定位旁路。针对每个病例离线测量预测成功的历史心内膜参数,这些参数与所提出的工作流程自动标注的消融靶点相对应。这种新型标测工作流程有望提高显性旁路存在时RFCA的疗效。